Antiangiogenic Effect of a Selective 5-HT4 Receptor Agonist1

Journal of Surgical Research

Volumn 159, Issue 2, 2010, Pages 696-704

  Nishikawa, Takeshi ^a   Tsuno, Nelson H ^a,b   Shuno, Yasutaka ^a   Sasaki, Kazuhito ^a   Hongo, Kumiko ^a   Okaji, Yurai ^b   Sunami, Eiji ^a   Kitayama, Joji ^a   Takahashi, Koki ^b   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

angiogenesis inhibitor; cell cycle arrest; HUVECs; mosapride citrate

Indexed keywords

ANTIMITOTIC AGENT; MATRIGEL; MOSAPRIDE CITRATE; PROKINETIC AGENT; SCLEROPROTEIN; SEROTONIN 4 AGONIST;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL ASSAY; CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; ENDOTHELIUM CELL; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; APOPTOSIS; BENZAMIDES; CELL ADHESION; CELL DIVISION; CELL HYPOXIA; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; MODELS, MOLECULAR; MORPHOLINES; NEOPLASMS; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN AGONISTS; UMBILICAL VEINS;

EID: 77949432551     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.11.004     Document Type: Article

References (33)

1. Folkman J., and Shing Y. Angiogenesis. J Biol Chem 267 (1992) 10931
2. Okaji Y., Tsuno N.H., Saito S., et al. Vaccines targeting tumor angiogenesis-a novel strategy for cancer immunotherapy. Eur J Surg Oncol 32 (2006) 1
3. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249
4. Folkman J., and Kalluri R. Cancer without disease. Nature 427 (2004) 787
5. Kawai K., Tsuno N.H., Kitayama J., Okaji Y., et al. Antiangiogenic properties of plaunotol. Anti-Cancer Drugs 16 (2005) 401
6. Asakage M., Tsuno N.H., Kitayama J., et al. Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis. Angiogenesis 9 (2006) 83
7. Asakage M., Tsuno N.H., Kitayama J., et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest. Anti-Cancer Drugs 15 (2004) 625
8. Mylecharane E.J. Mechanisms involved in serotonin-induced vasodilatation. Blood Vessels 27 (1990) 116
9. Martin G.R. Vascular receptors for 5-hydroxytryptamine: Distribution, function and classification. Pharmacol Ther 62 (1994) 283
10. Hoyer D., Clarke D.E., Fozard J.R., et al. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46 (1994) 157
11. Toga T., Kohmura Y., and Kawatsu R. The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities. J Pharmacol Sci 105 (2007) 207
12. Ruth M, Hamelin B, Rohss K, et al. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-esophageal reflux disease. Aliment Pharmacol Ther 198;12:35.
13. Tomita R., Ikeda T., Fujisaki S., et al. Effect of mosapride citrate on patients after vagal nerve preserving distal gastrectomy reconstructed by interposition of a jejunal J pouch with a jejunal conduit for early gastric cancer. World J Surg 30 (2006) 205
14. Ishizuka J., Beauchamp D., Townsend Jr. C.M., et al. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol 150 (1992) 1
15. Tutton P.J.M., and Barkla D.H. Biogenic amines as regulators of proliferative activity of normal and neoplastic intestinal epithelial cells (review). Anticancer Res 7 (1987) 1
16. Cattaneo M.G., Codignola A., Vicentini L.M., et al. Nicotine stimulates a serotoninergic autocrine loop in human small-cell lung carcinoma. Cancer Res 53 (1993) 5566
17. Sonier B., Lavigne C., Arseneault M., et al. Expression of the 5-HT2A serotoninergic receptor in human placenta and choriocarcinoma cells: Mitogenic implications of serotonin. Placenta 26 (2005) 484
18. Sonier B., Arseneault M., Lavigne C., et al. The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochem Biophys Res Commun 343 (2006) 1053
19. Dizeyi N., Bjartell A., Hedlund P., et al. Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines. Eur Urol 47 (2005) 895
20. Okaji Y., Tsuno N.H., Kitayama J., et al. Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity. Cancer Sci 95 (2004) 85
21. Kawai K., Tsuno N.H., Kitayama J., et al. Epigallocatechin gallate attenuates adhesion and migration of CD8 T cells by binding to CD11b. J Allergy Clin Immunol 113 (2004) 1211
22. Mallo G.V., Soubeyran P., Lissitzky J.C., et al. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer derived cells. J Biol Chem 273 (1998) 14030
23. Jeffers M., McDonald W.F., Chillakuru R.A., et al. A novel human fibroblast growth factor treats experimental intestinal inflammation. Gastroenterology 123 (2002) 1151
24. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 277 (1997) 48
25. 3-dependent endothelial cell adhesion, Rac activation, and spreading through cAMP/PKA-dependent signaling. J Biol Chem 277 (2002) 45838
26. 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration, and angiogenesis. Nat med 7 (2001) 1041
27. 3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat Med 4 (1998) 408
28. Tshuchiya T., Okaji Y., Tsuno N.H., et al. Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci 96 (2005) 784
29. Marcondes S., Lafay M., Bohn B.B., et al. Platelets induced human umbilical vein endothelial cell proliferation through P-selectin. Life Sci 66 (2000) 1817
30. Pakala R., and Benedict C.R. Effect of serotonin and thromboxane A2 on endothelial cell proliferation: Effect of specific receptor antagonist. J Lab Clin Med 131 (1999) 527
31. Matsusaka S., and Wakabayashi I. 5-Hydroxytryptamine as a potent migration enhancer of human aortic endothelial cells. FEBS Lett 579 (2005) 6721
32. Sakashita M., Yamaguchi T., Miyazaki H., et al. Pharmacokinetics of the Gastrokinetic agent mosapride citrate after single and multiple oral administration in healthy subjects. Arzneim-Forsh/Drug Res 43 (1993) 867
33. 14C]-mosapride citrate after a single oral administration in rats, dogs, and monkeys. Arzneim-Forsh/Drug Res 43 (1993) 1084